FDA approves AstraZeneca, Sanofi shot that protects infants and toddlers against RSV

RSV is the leading cause of hospitalization among children less than a year old, according to scientists.

Previous post Brett Arends’s ROI: $100,000 worth of investments for $85,000? In this market?
Next post : FDA approves Sanofi and AstraZeneca infant RSV vaccine